Assessment of Quality of Life Among Patients With Recurrent Clostridioides difficile Infection Treated with Investigational Oral Microbiome Therapeutic SER-109: Secondary Analysis of a Randomized Clinical Trial

IMPORTANCE: Recurrent Clostridioides difficile infection (CDI) is a debilitating disease leading to poor health-related quality of life (HRQOL), loss of productivity, anxiety, and depression. The potential association of treatment with HRQOL has not been well evaluated. OBJECTIVES: To explore the as...

Descripción completa

Detalles Bibliográficos
Autores principales: Garey, Kevin W., Jo, Jinhee, Gonzales-Luna, Anne J., Lapin, Brittany, Deshpande, Abhishek, Wang, Elaine, Hasson, Brooke, Pham, Sissi V., Huang, Shirley P., Reese, Pat Ray, Wu, Henry, Hohmann, Elizabeth, Feuerstadt, Paul, Oneto, Caterina, Berenson, Charles S., Lee, Christine, McGovern, Barbara, vonMoltke, Lisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9887497/
https://www.ncbi.nlm.nih.gov/pubmed/36716031
http://dx.doi.org/10.1001/jamanetworkopen.2022.53570

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9887497/
https://www.ncbi.nlm.nih.gov/pubmed/36716031
http://dx.doi.org/10.1001/jamanetworkopen.2022.53570

Ejemplares similares